North America Embolization Coils Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The North America Embolization Coils Market size is expected to reach US$ 1,503.2 Million by 2031 from US$ 758.6 Million in 2024. The market is estimated to record a CAGR of 10.4% from 2025 to 2031.

Executive Summary and North America Embolization Coils Market Analysis:

The North America embolization coils market is segmented into the US, Canada, and Mexico. The rising prevalence of neurovascular disorders, such as aneurysms, coupled with an increasing cancer burden that necessitates minimally invasive embolization procedures, is driving significant growth in demand for embolization coils. In North America, an aging population further amplifies market expansion, as older individuals are more susceptible to vascular abnormalities. Continuous advancements in coil technology-enhancing material composition, deliverability, and radiopacity-have improved procedural success rates, accelerating clinical adoption. The region benefits from a strong presence of leading medical device manufacturers, ensuring robust product availability and fostering competitive innovation. Favorable reimbursement frameworks and high healthcare expenditure further support widespread utilization of embolization procedures across hospitals and ambulatory surgical centers. Additionally, the growing preference for minimally invasive interventions, driven by shorter recovery times and reduced complication risks, is shifting clinical practice away from traditional surgery toward embolization. Increased physician awareness, broader adoption of image-guided techniques, and a rising number of interventional radiologists continue to reinforce market growth.

North America Embolization Coils Market: Strategic Insights

North America Embolization Coils Market Segmentation Analysis:

• By Embolization Coils, the North America Embolization Coils Market is segmented into Central Application and Peripheral Application. The Central Application segment dominated the market in 2024.
• By Application, the North America Embolization Coils Market is segmented into Neurology, Peripheral Vascular Disease, Oncology, Urology, and Others. The Neurology segment dominated the market in 2024.
• By End User, the North America Embolization Coils Market is segmented into Hospital, Ambulatory Centers, and Others. The Hospital segment dominated the market in 2024.

North America Embolization Coils Market Players Density: Understanding Its Impact on Business Dynamics

The North America Embolization Coils Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Embolization Coils Market Outlook

Aneurysms are characterized by weakened blood vessel walls that bulge and risk rupture. Globally, approximately 3% of adults harbor unruptured intracranial aneurysms, with prevalence climbing to 10% in high-risk groups such as those with family history or connective tissue disorders. According to the Brain Aneurysm Foundation estimates, in the US alone, an estimated 6.8 million individuals-about 1 in 50 people-live with unruptured brain aneurysms, underscoring the silent epidemic. A brain aneurysm bursts every 18 minutes worldwide, contributing to nearly 500,000 deaths annually, with half the victims under age 50.

The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) highlight that such events often lead to subarachnoid hemorrhage, with mortality rates exceeding 40% in the first month. Embolization coils have revolutionized the management of aneurysms; since the landmark International Subarachnoid Aneurysm Trial in 2002, coiling has become the gold standard for many unruptured cases, achieving occlusion rates of over 90% while minimizing neurological deficits.

Peripheral artery disease (PAD)-another vascular scourge-further fuels coil adoption. According to the article "Income-Related Peripheral Artery Disease Treatment," published in the National Library of Medicine in 2022, more than 200 million people worldwide suffer from PAD. PAD's prevalence rose 72% from 65.8 million in 1990 to 113.4 million in 2019, driven by rising diabetes and obesity. PAD often manifests as leg pain or ulcers, but can lead to aneurysms in peripheral vessels. Embolization coils treat these by embolizing feeder arteries, halting progression and averting amputations, which affect over 230,000 Americans yearly, per CDC data.

This rising tide demands scalable solutions. Embolization coils have moved from an innovative alternative to the preferred first-line therapy for many intracranial and peripheral aneurysms. Developments in coil design, such as bioactive coatings for better endothelialization, enhance durability and reduce recanalization risks to under 10%. As screening programs expand and imaging technology detects more incidental aneurysms, the pool of treatable lesions will continue to grow. Thus, the rising prevalence of vascular disorders guarantees long-term, structural growth for embolization coil technologies.

North America Embolization Coils Market Country Insights

By country, the North America Embolization Coils Market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2024.

According to the Brain Aneurysm Foundation, approximately 6.8 million Americans live with unruptured brain aneurysms, impacting nearly 1 in 50 individuals. The annual rupture incidence is estimated at 8-10 cases per 100,000 people. The American Heart Association reports that Peripheral Artery Disease (PAD) affects 7-12 million adults, contributing to over 400 nontraumatic amputations daily and positioning PAD as a leading cause of limb loss. These conditions significantly drive demand for embolization coils, which are widely utilized in procedures such as coil occlusion for cerebral aneurysms. In these interventions, detachable platinum coils are delivered via endovascular access to induce thrombosis within the aneurysm sac, preventing rupture. Peripheral applications include embolization of arteriovenous malformations in the legs, aimed at alleviating ischemic pain and restoring blood flow.

Recent advancements have accelerated coil adoption. In October 2025, Penumbra introduced the SwiftSET Neuro Embolization Coil, designed for precise deployment in complex neurovascular anatomies. Its adaptive framing technology enhances packing density and reduces procedural time. In November 2025, the first US surgery utilizing a polymer-based biodegradable coil was performed in Delaware. This innovation promotes faster endothelialization and lowers long-term recanalization risk compared to traditional metal coils. Additionally, Embolization, Inc. secured FDA 510(k) clearance in June 2025 for the Nitinol Enhanced Device (NED), a non-metallic coil alternative that minimizes imaging artifacts, enabling improved post-procedure monitoring.

The aging US population increases vulnerability to vascular pathologies such as aneurysms and PAD, driven by cumulative endothelial damage and hypertension. Technological breakthroughs, such as hydrogel-infused coils that enhance clot stability and reduce migration, have shifted treatment paradigms from open surgical clipping to minimally invasive coiling, achieving success rates above 90% in unruptured cases. Public health initiatives by organizations like the Society of Interventional Radiology have improved early screening, while rising healthcare investments in endovascular suites expand procedural access.

Embolization coils are emerging as a cornerstone of preventive vascular care. Ongoing clinical trials, such as the WAVE Extra Soft Coils study, report 95% sustained occlusion in high-risk patients over five years. As precision delivery systems advance, the integration of AI-guided coil placement is leading in the US to optimize outcomes and support continued growth in procedure volumes through 2030.

North America Embolization Coils Market Company Profiles

Some of the key players operating in the market include Cook Medical Holdings LLC, Terumo Corp, Boston Scientific Corp, Medtronic Plc, Stryker Corp, Balt, Wallaby Medical, NeuroSafe Medical Co. Ltd, INVAMED, and Penumbra Inc.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Embolization Coils Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise